MedTrace Logo

Epi-GERD Study: Epidemiological Evaluation in Patients With Gastro-Esophageal Reflux Disease (GERD)

NCT04094402 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2019-09-23

No results posted yet for this study

Summary

Cross-sectional epidemiological study in patients with diagnosis of GERD (Gastroesophageal Reflux Disease) and with current treatment or with a history of recent treatment with some PPI (Proton Pump Inhibitor), in order to evaluate the persistence and / or relapse of symptoms of GERD.

Conditions

  • Gastroesophageal Reflux Disease

Interventions

OTHER

None. It is an observational study

None. It is an observational study

Sponsors & Collaborators

  • Scandinavia Pharma

    lead INDUSTRY

Principal Investigators

  • Javier Castillo, Dr · Medical Director

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-04
Primary Completion
2023-12-31
Completion
2024-07-31

Countries

  • Colombia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04094402 on ClinicalTrials.gov